Medscape June 24, 2024
Brain imaging combined with artificial intelligence has identified six distinct “biotypes” of depression and anxiety that may lead to more personalized and effective treatment.
This research has “immediate clinical implications,” study investigator Leanne Williams, PhD, director of the Stanford Medicine Center for Precision Mental Health and Wellness, told Medscape Medical News.
“At Stanford, we have started translating the imaging technology into use in a new precision mental health clinic. The technology is being actively developed for wider use in clinical settings, and we hope to make it accessible to more clinicians and patients,” Williams said.
The study was published online on June 17, 2024, in Nature Medicine.
No More Trial and Error?
Depression is a highly heterogeneous disease, with individual...
Today's Sponsors
Today's Sponsor